The Procter & Gamble Company (NYSE:PG) Shares Sold by Lynch & Associates IN

Lynch & Associates IN reduced its position in The Procter & Gamble Company (NYSE:PG) by 2.8% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 89,576 shares of the company’s stock after selling 2,600 shares during the period. Procter & Gamble accounts for approximately 3.4% of Lynch & Associates IN’s investment portfolio, making the stock its 4th largest holding. Lynch & Associates IN’s holdings in Procter & Gamble were worth $14,534,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in PG. Advantage Trust Co bought a new position in Procter & Gamble during the fourth quarter worth about $28,000. Wyrmwood Management LLC bought a new stake in shares of Procter & Gamble in the fourth quarter valued at about $29,000. Naples Money Management LLC bought a new stake in shares of Procter & Gamble in the fourth quarter valued at about $29,000. Transcendent Capital Group LLC bought a new stake in shares of Procter & Gamble in the fourth quarter valued at about $31,000. Finally, Criterion Capital Advisors LLC bought a new stake in shares of Procter & Gamble in the fourth quarter valued at about $33,000. 65.77% of the stock is owned by institutional investors and hedge funds.

Procter & Gamble Stock Performance

NYSE PG opened at $167.73 on Friday. The company has a quick ratio of 0.48, a current ratio of 0.69 and a debt-to-equity ratio of 0.49. The stock has a fifty day simple moving average of $164.33 and a 200 day simple moving average of $157.89. The Procter & Gamble Company has a twelve month low of $141.45 and a twelve month high of $168.97. The company has a market capitalization of $395.87 billion, a price-to-earnings ratio of 27.41, a PEG ratio of 3.42 and a beta of 0.42.

Procter & Gamble (NYSE:PG) last issued its quarterly earnings results on Friday, April 19th. The company reported $1.52 earnings per share for the quarter, topping analysts’ consensus estimates of $1.42 by $0.10. Procter & Gamble had a return on equity of 33.91% and a net margin of 18.00%. The firm had revenue of $20.20 billion during the quarter, compared to the consensus estimate of $20.43 billion. During the same period last year, the business posted $1.37 EPS. The business’s revenue was up .6% compared to the same quarter last year. Sell-side analysts expect that The Procter & Gamble Company will post 6.55 EPS for the current year.

Procter & Gamble Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th were given a dividend of $1.0065 per share. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.40%. The ex-dividend date of this dividend was Thursday, April 18th. This is a boost from Procter & Gamble’s previous quarterly dividend of $0.94. Procter & Gamble’s dividend payout ratio is 65.85%.

Insider Activity at Procter & Gamble

In related news, CEO R. Alexandra Keith sold 855 shares of the firm’s stock in a transaction dated Monday, April 22nd. The shares were sold at an average price of $158.50, for a total value of $135,517.50. Following the transaction, the chief executive officer now owns 4,004 shares of the company’s stock, valued at approximately $634,634. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. In other news, CEO Gary A. Coombe sold 21,388 shares of the firm’s stock in a transaction that occurred on Tuesday, May 7th. The shares were sold at an average price of $164.98, for a total transaction of $3,528,592.24. Following the completion of the sale, the chief executive officer now owns 36,854 shares in the company, valued at approximately $6,080,172.92. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO R. Alexandra Keith sold 855 shares of the firm’s stock in a transaction that occurred on Monday, April 22nd. The stock was sold at an average price of $158.50, for a total transaction of $135,517.50. Following the sale, the chief executive officer now owns 4,004 shares of the company’s stock, valued at approximately $634,634. The disclosure for this sale can be found here. In the last quarter, insiders have sold 154,544 shares of company stock valued at $25,413,051. 0.17% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

PG has been the topic of a number of research reports. Argus boosted their price target on Procter & Gamble from $180.00 to $185.00 and gave the company a “buy” rating in a report on Thursday, April 25th. Barclays lifted their target price on Procter & Gamble from $168.00 to $170.00 and gave the company an “overweight” rating in a research report on Tuesday, April 23rd. Jefferies Financial Group lifted their target price on Procter & Gamble from $175.00 to $182.00 and gave the company a “buy” rating in a research report on Monday, April 22nd. The Goldman Sachs Group assumed coverage on Procter & Gamble in a research report on Friday, March 1st. They issued a “neutral” rating and a $168.00 target price on the stock. Finally, Truist Financial raised Procter & Gamble from a “hold” rating to a “buy” rating and boosted their price target for the stock from $160.00 to $175.00 in a research report on Monday, March 11th. Seven analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat.com, Procter & Gamble has an average rating of “Moderate Buy” and a consensus price target of $169.76.

About Procter & Gamble

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.